Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple Sclerosis

Publisher： Karger

E-ISSN： 1423-0216|16|3|171-176

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.16, Iss.3, 2009-02, pp. : 171-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 213-222

Karger

Access to resources Recommend Favorite

TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 20, Iss. 3, 2013-04 ,pp. : 177-183

Karger

Access to resources Recommend Favorite

Corticosterone Changes in Response to Stressors, Acute and Protracted Actions of Tumor Necrosis Factor-α, and Lipopolysaccharide Treatments in Mice Lacking the Tumor Necrosis Factor-α p55 Receptor Gene

By  

Neuroimmunomodulation, Vol. 11, Iss. 4, 2004-07 ,pp. : 241-246

Karger

Access to resources Recommend Favorite

Tumor Necrosis Factor and Motoneuronal Degeneration: An Open Problem

By  

Neuroimmunomodulation, Vol. 9, Iss. 4, 2002-02 ,pp. : 178-182

Karger

Access to resources Recommend Favorite

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite